chr3-38633221-TG-CA
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM1PM2PP2
The ENST00000423572.7(SCN5A):c.86_87inv(p.Ala29Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Uncertain significancein ClinVar. Synonymous variant affecting the same amino acid position (i.e. A29A) has been classified as Likely benign.
Frequency
Consequence
ENST00000423572.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_000335.5 | c.86_87inv | p.Ala29Val | missense_variant | 2/28 | ENST00000423572.7 | NP_000326.2 | |
SCN5A | NM_001099404.2 | c.86_87inv | p.Ala29Val | missense_variant | 2/28 | ENST00000413689.6 | NP_001092874.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.86_87inv | p.Ala29Val | missense_variant | 2/28 | 5 | NM_001099404.2 | ENSP00000410257 | P4 | |
SCN5A | ENST00000423572.7 | c.86_87inv | p.Ala29Val | missense_variant | 2/28 | 1 | NM_000335.5 | ENSP00000398266 | A1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2022 | A nucleotide substitution (c.86C>T) which results in the same amino acid substitution, A29V, has been reported in a patient with presyncope and a QTc of 490ms, who also harbored a pathogenic variant in the KCNQ1 gene (Stattin et al., 2012); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23098067, 33221895) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2024 | This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 29 of the SCN5A protein (p.Ala29Val). This variant is present in population databases (rs794728905, gnomAD 0.008%). This missense change has been observed in individual(s) with SCN5A-related conditions (PMID: 23098067, 28611029, 33221895). ClinVar contains an entry for this variant (Variation ID: 242209). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The valine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
SCN5A-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 08, 2023 | The SCN5A c.86_87delinsTG variant is predicted to result in an in-frame deletion and insertion. This variant was reported in an individual with Brugada syndrome (Table S5, Ciconte et al. 2020. PubMed ID: 33221895). Of note, this variant may be reported in a large population database as two separate entries as c.87A>G (https://gnomad.broadinstitute.org/variant/3-38674712-T-C) and c.86C>T (https://gnomad.broadinstitute.org/variant/3-38674713-G-A). A similar variant resulting in the same amino acid substitution, c.86C>T (p.Ala29Val), has been reported in individuals with long QT syndrome, dilated cardiomyopathy, or sudden death (Stattin et al. 2012. PubMed ID: 23098067; Table S2, Methner et al. 2016. PubMed ID: 27435932; Table S2, Haskell et al. 2017. PubMed ID: 28611029). At this time, the clinical significance of the c.86_87delinsTG (p.Ala29Val) variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 10, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.86_87delCAinsTG variant (also known as p.A29V), located in coding exon 1 of the SCN5A gene, results from an in-frame deletion of CA and insertion of TG at nucleotide positions 86 to 87. This results in the substitution of the alanine residue for a valine residue at codon 29, an amino acid with similar properties. This alteration has been reported in a Brugada syndrome cohort; however, clinical details were limited (Ciconte G et al. Eur Heart J, 2021 03;42:1082-1090). Another alteration at the same codon, p.A29V (c.86C>T), has been described in individuals with a prolonged QT interval and a sudden unexplained infant death cohort (Stattin EL et al. BMC Cardiovasc Disord, 2012 Oct;12:95; Methner DN et al. Genome Res, 2016 09;26:1170-7; Haskell GT et al. Circ Cardiovasc Genet, 2017 Jun;10:[ePub ahead of print]). Based on data from gnomAD, the TG allele has an overall frequency of 0.008% (22/280148) total alleles studied. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be inconclusive by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Cardiac arrhythmia Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Oct 11, 2022 | This missense variant replaces alanine with valine at codon 29 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). A functional study has shown this variant reduces the sodium inward current (Murano et. al, 2019). This variant has been reported in an individual affected with Brugada syndrome (Murano et. al, 2019). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at